Article
Clinical Outcomes of Early Phenotype-Desirable Antimicrobial Therapy for Enterobacterales Bacteremia.
JAMA network open - 2 Dec 2024
Moon Rena C, MacVane Shawn H, David Joy, Morton Jacob B, Rosenthal Ning, Claeys Kimberly C
Abstract excerpt
Importance: Initiating effective therapy early is associated with improved survival among patients hospitalized with gram-negative bloodstream infections; furthermore, providing early phenotype-desirable antimicrobial therapy (PDAT; defined as receipt of a β-lactam antibiotic with the narrowest spectrum of activity to effectively treat the pathogen's phenotype) is crucial for antimicrobial stewardship. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
